معرفی
Dhruva Biswas is an Associate Research Scientist at the Yale School of Medicine and a Clinician-Data Scientist at the Cardiovascular Data Science (CarDS) Lab. His research focuses on integrating AI-driven insights into clinical practice, particularly in cardiovascular care and cancer biomarker development. He holds MD and PhD degrees from University College London (2022), with a PhD thesis on molecular portraits of cancer evolution at the UCL Cancer Institute and Francis Crick Institute.
Education: MA in Neuroscience (University of Cambridge, 2015), MB/PhD in Medicine and Molecular Cancer Biology (University College London, 2022), and Academic Foundation training in Cardiology (King’s College London).
Research Interests:
- AI in healthcare diagnostics and personalized medicine
- Development of molecular and digital biomarkers for high-risk patient identification
- Cancer evolution and clonal heterogeneity
- Health equity in cardiovascular interventions
Notable Articles: Focus on AI-driven biomarker validation (e.g., ORACLE for lung cancer prognosis), cardiovascular AI applications, and genomic analyses of cancer progression. His work has been published in Nature Medicine, Nature Cancer, and European Heart Journal Digital Health.
Awards: Recognized as a Francis Crick Institute Translation Fellow (2021), Sir David Cooksey Translation Prize (2020), and featured in Nature Medicine as ‘at the forefront of medical research’.
Advocacy & Mentorship: Supervised MSc students achieving distinction grades, involved in South London structural heart equity initiatives, and promotes patient/public involvement in research.
Labs: Cardiovascular Data Science (CarDS) Lab at Yale School of Medicine.
